Oncology patients treated with an immune checkpoint inhibitor (ICI) may require admission to the intensive care unit (ICU).
Less than 2% of patients treated with immune complex inhibitors required ICU admission.
Immune complications associated with ICU admission:
(1) myocarditis
(2) pneumonitis
(3) myasthenia gravis
(4) severe colitis
Non-immune conditions:
(1) pneumonia
(2) pulmonary embolism
(3) complete heart block
(4) cancer progression
(5) sepsis
(6) COVID-19
Therapy for immune complications:
(1) high-dose corticosteroid therapy
(2) at least 1 immunosuppressive agent
Most patients admitted for an immune complication survived the ICU admission.
To read more or access our algorithms and calculators, please log in or register.
Specialty: Pulmonology, Critical Care
